Imidazolyl amide compounds and uses related thereto

US9365523B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9365523-B2
Application numberUS-201214006259-A
CountryUS
Kind codeB2
Filing dateMar 28, 2012
Priority dateMar 31, 2011
Publication dateJun 14, 2016
Grant dateJun 14, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This disclosure relates to antiviral compounds disclosed herein and uses related thereto. In certain embodiments, the disclosure relates to pharmaceutical compositions comprising 2-((benzo[d]imidazol-2-yl)thio)-N-phenylpropanamide derivatives, N-phenyl-2-((1-phenyl-benzo[d]imidazol-2-yl)thio)propanamide derivatives, or 2-((benzo[d]imidazol-2-yl)thio)-N-(2-chloro-4-methylphenyl)propanamide derivatives. The derivatives may be substituted with one or more substituents. Typically, the pharmaceutical composition comprises a compound of Formula (I), or salt, prodrug, or ester thereof wherein X, Y, and R1 to R7 are described herein.

First claim

Opening claim text (preview).

What is claimed: 1. A pharmaceutical composition comprising a pharmaceutically acceptable carrier, diluent or excipient and a compound selected from: N-(2-chloro-4-methylphenyl)-2-((1-(4-(morpholinomethyl)phenyl)-benzo[d]imidazol-2-yl)thio)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(4-(cyanomethoxy)phenyl)-benzo[d]imidazol-2-yl)thio)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(4-(2-hydroxyethoxy)phenyl)-benzo[d]imidazol-2-yl)thio)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(4-(2-(dimethylamino)ethyl)amino)phenyl)-benzo[d]imidazol-2-yl)thio)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(4-(2-(dimethylamino)ethyl)(methyl)amino)phenyl)-benzo[d]imidazol-2-yl)thio)propanamide; 2-((1-(4-(2-acetamidoethoxy)phenyl)-benzo[d]imidazol-2-yl)thio)-N-(2-chloro-4-methylphenyl)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(4-(2-oxoethyl)phenyl)-benzo[d]imidazol-2-yl)thio)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(4-(2-hydroxyethyl)phenyl)-benzo[d]imidazol-2-yl)thio)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(4-(2-(methylamino)ethyl)phenyl)-benzo[d]imidazol-2-yl)thio)propanamide; 2-(4-(2-((1-(2-chloro-4-methylphenyl)amino)-1-oxopropan-2-yl)thio)-benzo[d]imidazol-1-yl)phenoxy)acetic acid; methyl 2-(4-(2-((1-((2-chloro-4-methylphenyl)amino)-1-oxopropan-2-yl)thio)-benzo[d]imidazol-1-yl)phenoxy)acetate; 2-((1-(4-aminophenyl)-benzo[d]imidazol-2-yl)thio)-N-(2-chloro-4-methylphenyl)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(4-hydroxyphenyl)-benzo[d]imidazol-2-yl)thio)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(4-ethoxyphenyl)-benzo[d]imidazol-2-yl)thio)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(4-(dimethylamino)phenyl)-benzo[d]imidazol-2-yl)thio)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(4-(4-methylpiperazin-1-yl)phenyl)-benzo[d]imidazol-2-yl)thio)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(4-morpholinophenyl)-benzo[d]imidazol-2-yl)thio)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(4-(hydroxymethyl)phenyl)-benzo[d]imidazol-2-yl)thio)propanamide; 2-((1-(4-azidophenyl)-benzo[d]imidazol-2-yl)thio)-N-(2-chloro-4-methylphenyl)propanamide; 4-(2-((1-(2-chloro-4-methylphenyl)amino)-1-oxopropan-2-yl)thio)-benzo[d]imidazol-1-yl)benzoic acid; N-(2-chloro-4-methylphenyl)-2-((1-(4-((dimethylamino)methyl)phenyl)-benzo[d]imidazol-2-yl)thio)propanamide; methyl 4-(2-((1-((2-chloro-4-methylphenyl)amino)-1-oxopropan-2-yl)thio)-benzo[d]imidazol-1-yl)benzoate; N-(2-chloro-4-methylphenyl)-2-((1-(4-methoxyphenyl)-benzo[d]imidazol-2-yl)thio)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-phenyl-benzo[d]imidazol-2-yl)thio)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(3-methoxyphenyl)-benzo[d]imidazol-2-yl)thio)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(m-tolyl)-benzo[d]imidazol-2-yl)thio)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(3,5-dimethoxyphenyl)-benzo[d]imidazol-2-yl)thio)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(3-(morpholinomethyl)phenyl)-benzo[d]imidazol-2-yl)thio)propanamide; 3-(2-((1-((2-chloro-4-methylphenyl)amino)-1-oxopropan-2-yl)thio)-benzo[d]imidazol-1-yl)benzoic acid; N-(2-chloro-4-methylphenyl)-2-((1-(2-(morpholinomethyl)phenyl)-benzo[d]imidazol-2-yl)thio)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(3-(hydroxymethyl)phenyl)-benzo[d]imidazol-2-yl)thio)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(2-(hydroxymethyl)phenyl)-benzo[d]imidazol-2-yl)thio)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(4-methoxybenzyl)-benzo[d]imidazol-2-yl)thio)propanamide; N-(2-chloro-4-methylphenyl)-2-((1-(phenylsulfonyl)-benzo[d]imidazol-2-yl)thio)propanamide; and N-(2,4-dichlorophenyl)-2-((1-(4-methoxybenzyl)-benzo[d]imidazol-2-yl)thio)propanamide, or salts thereof.

Assignees

Inventors

Classifications

  • condensed with carbocyclic rings, e.g. benzimidazoles · CPC title

  • not condensed and containing further heterocyclic rings · CPC title

  • linked by a carbon chain containing only aliphatic carbon atoms · CPC title

  • containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K31/465) · CPC title

  • linked by a chain containing hetero atoms as chain links · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9365523B2 cover?
This disclosure relates to antiviral compounds disclosed herein and uses related thereto. In certain embodiments, the disclosure relates to pharmaceutical compositions comprising 2-((benzo[d]imidazol-2-yl)thio)-N-phenylpropanamide derivatives, N-phenyl-2-((1-phenyl-benzo[d]imidazol-2-yl)thio)propanamide derivatives, or 2-((benzo[d]imidazol-2-yl)thio)-N-(2-chloro-4-methylphenyl)propanamide deriv…
Who is the assignee on this patent?
Plemper Richard K, Snyder James P, Sun Aiming, and 4 more
What technology area does this patent fall under?
Primary CPC classification C07D235/28. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).